The absence of a COL1A2 murine OI model with autosomal dominant inheritance, mild to moderate disease, and phenotype variation represents a major gap in our tools to understand OI pathobiology and to develop effective treatment. This evidence concerns the gene COL1A2 and osteogenesis imperfecta.